BioSpace News Archive

Omnicell, Inc., a leader in transforming the pharmacy care delivery model, announced results for its first quarter ended March 31, 2023.

Jazz Pharmaceuticals plc announced that the Company will participate in the 2023 RBC Capital Markets Global Healthcare Conference.

Varex Imaging Corporation announced its unaudited financial results for the second quarter of fiscal year 2023.

Spruce Biosciences, Inc. announced that company management will participate in two upcoming investor conferences taking place in May.

Arbor Biotechnologies® today announced that three abstracts were selected for poster presentation at the upcoming American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting being held from May 16-20, 2023, in Los Angeles, CA.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter 2023.

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, announced that the Company granted stock options to two new employees to purchase an aggregate of 23,100 shares of the Company’s common stock, effective as of May 1, 2023.

Adverum Biotechnologies, Inc. announced new data will be presented during the American Society of Gene & Cell Therapy 2023 Annual Meeting being held May 16-20, 2023, in Los Angeles, California.

Poseida Therapeutics, Inc. (Nasdaq: PSTX) today announced that six data presentations, including two oral presentations, highlighting the Company’s preclinical gene therapy programs and platforms will be presented at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting.

Aquestive Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2023 and provided an update on recent developments in its business.